319 related articles for article (PubMed ID: 27221203)
1. VOC breath biomarkers in lung cancer.
Saalberg Y; Wolff M
Clin Chim Acta; 2016 Aug; 459():5-9. PubMed ID: 27221203
[TBL] [Abstract][Full Text] [Related]
2. Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis.
Zhou J; Huang ZA; Kumar U; Chen DDY
Anal Chim Acta; 2017 Dec; 996():1-9. PubMed ID: 29137702
[TBL] [Abstract][Full Text] [Related]
3. Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics.
Buszewski B; Ulanowska A; Kowalkowski T; Cieśliński K
Clin Chem Lab Med; 2011 Oct; 50(3):573-81. PubMed ID: 22035139
[TBL] [Abstract][Full Text] [Related]
4. Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.
Phillips M; Bauer TL; Cataneo RN; Lebauer C; Mundada M; Pass HI; Ramakrishna N; Rom WN; Vallières E
PLoS One; 2015; 10(12):e0142484. PubMed ID: 26698306
[TBL] [Abstract][Full Text] [Related]
5. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
[TBL] [Abstract][Full Text] [Related]
6. A volatile biomarker in breath predicts lung cancer and pulmonary nodules.
Phillips M; Bauer TL; Pass HI
J Breath Res; 2019 Jun; 13(3):036013. PubMed ID: 31085817
[TBL] [Abstract][Full Text] [Related]
7. Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis.
Sun X; Shao K; Wang T
Anal Bioanal Chem; 2016 Apr; 408(11):2759-80. PubMed ID: 26677028
[TBL] [Abstract][Full Text] [Related]
8. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
[TBL] [Abstract][Full Text] [Related]
9. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study.
Poli D; Carbognani P; Corradi M; Goldoni M; Acampa O; Balbi B; Bianchi L; Rusca M; Mutti A
Respir Res; 2005 Jul; 6(1):71. PubMed ID: 16018807
[TBL] [Abstract][Full Text] [Related]
10. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
[TBL] [Abstract][Full Text] [Related]
11. Rapid recognition of volatile organic compounds with colorimetric sensor arrays for lung cancer screening.
Zhong X; Li D; Du W; Yan M; Wang Y; Huo D; Hou C
Anal Bioanal Chem; 2018 Jun; 410(16):3671-3681. PubMed ID: 29654337
[TBL] [Abstract][Full Text] [Related]
12. Real-time ultrasensitive VUV-PIMS detection of representative endogenous volatile markers in cancers.
Li Z; Shu J; Zhang P; Sun W; Yang B; Zhang H
Cancer Biomark; 2016; 16(3):477-87. PubMed ID: 27062705
[TBL] [Abstract][Full Text] [Related]
13. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review.
Oakley-Girvan I; Davis SW
Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925
[TBL] [Abstract][Full Text] [Related]
14. Detection of volatile organic compounds in exhaled breath to screen lung cancer: a systematic review.
Hua Q; Zhu Y; Liu H
Future Oncol; 2018 Jul; 14(16):1647-1662. PubMed ID: 29939068
[TBL] [Abstract][Full Text] [Related]
15. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
16. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
[TBL] [Abstract][Full Text] [Related]
17. VOC biomarkers identification and predictive model construction for lung cancer based on exhaled breath analysis: research protocol for an exploratory study.
Li W; Dai W; Liu M; Long Y; Wang C; Xie S; Liu Y; Zhang Y; Shi Q; Peng X; Liu Y; Li Q; Duan Y
BMJ Open; 2019 Aug; 9(8):e028448. PubMed ID: 31399453
[TBL] [Abstract][Full Text] [Related]
18. Assessment, origin, and implementation of breath volatile cancer markers.
Haick H; Broza YY; Mochalski P; Ruzsanyi V; Amann A
Chem Soc Rev; 2014 Mar; 43(5):1423-49. PubMed ID: 24305596
[TBL] [Abstract][Full Text] [Related]
19. Breath carbonyl compounds as biomarkers of lung cancer.
Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
[TBL] [Abstract][Full Text] [Related]
20. Volatile organic compounds as new biomarkers for colorectal cancer: a review.
Di Lena M; Porcelli F; Altomare DF
Colorectal Dis; 2016 Jul; 18(7):654-63. PubMed ID: 26752703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]